• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tarsus Pharmaceuticals, Inc. - Common Stock (NQ:TARS)

    56.98 -0.43 (-0.75%)
    Streaming Delayed Price Updated: 10:22 AM EDT, Jun 3, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Tarsus Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    News headline image
    Tarsus Announces Transition Plans for Board of Directors
    From Tarsus Pharmaceuticals, Inc
    Via GlobeNewswire
    News headline image
    Tarsus Appoints Scott Morrison as Board Member and Audit Committee Chair
    From Tarsus Pharmaceuticals, Inc
    Via GlobeNewswire
    News headline image
    Tarsus Launches “Look at the Lids” Campaign to Encourage Eye Care Professionals to Identify and Diagnose Demodex Blepharitis
    From Tarsus Pharmaceuticals, Inc
    Via GlobeNewswire
    News headline image
    Stocks That Hit 52-Week Lows On Tuesday ↗
    Tuesday's session saw 211 companies set new 52-week lows. 
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2022 ↗
    Upgrades 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours. 
    Via Benzinga
    News headline image
    66 Biggest Movers From Yesterday ↗
    Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged... 
    Via Benzinga
    News headline image
    31 Stocks Moving In Monday's Mid-Day Session ↗
    Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) climbed 64.9% to $9.86. Redbox recently reported CFO transition. SoundHound AI, Inc. (NASDAQ: SOUN) shares gained 30.5% to $8.48... 
    Via Benzinga
    News headline image
    The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More ↗
    Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering... 
    Via Benzinga
    News headline image
    Looking Into Tarsus Pharmaceuticals's Return On Capital Employed ↗
    According to Benzinga Pro data, during Q4, Tarsus Pharmaceuticals (NASDAQ:TARS) posted sales of $338.00 thousand. Earnings were up 5.39%, but Tarsus Pharmaceuticals still reported... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Thursday ↗
    During Thursday's morning trading, 152 companies set new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Rivian Automotive (NASDAQ:RIVN) was the largest... 
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For November 23, 2021 ↗
    Upgrades Keefe, Bruyette & Woods upgraded the previous rating for CBRE Group Inc (NYSE: 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Gainers Statera BioPharma (NASDAQ:STAB) shares increased by 16.92% to $3.16 during Wednesday's regular session. The market value of their outstanding shares is at $87.... 
    Via Benzinga
    News headline image
    2 Biotech Stocks Wall Street Predicts Will Double ↗
    Biotechnology is advancing rapidly, driven by robust investments in new developments and a demand for synthetic biology. The industry is expected to continue to generate significant growth over an... 
    Via Talk Markets
    News headline image
    3 Top Biotech Stocks to Buy Right Now ↗
    These three biotech stocks recently had positive news coming out of phase 2 trials, making them good choices for growth-oriented investors. 
    Via The Motley Fool
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Gainers Anavex Life Sciences (NASDAQ:AVXL) stock increased by 17.07% to $25.92 during Tuesday's regular session. As of 12:33 EST, this security is trading at a volume... 
    Via Benzinga
    News headline image
    48 Biggest Movers From Yesterday ↗
    Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share. New Concept Energy,... 
    Via Benzinga
    News headline image
    Mid-Afternoon Market Update: Dow Jumps Over 500 Points; Lydall Shares Spike Higher ↗
    Toward the end of trading Monday, the Dow traded up 1.71% to 33,857.87 while the NASDAQ rose 0.63% to 14,119.16. The S&P also rose, gaining 1.28% to 4,219.92. The U.S. has the... 
    Via Benzinga
    Topics Stocks
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Gainers Anavex Life Sciences (NASDAQ:AVXL) shares moved upwards by 17.07% to $25.92 during Monday's regular session. Anavex Life Sciences's stock is trading at a... 
    Via Benzinga
    News headline image
    Mid-Day Market Update: Crude Oil Rises 1.5%; Tarsus Pharmaceuticals Shares Slide ↗
    Midway through trading Monday, the Dow traded up 1.48% to 33,782.47 while the NASDAQ rose 0.74% to 14,134.01. The S&P also rose, gaining 1.17% to 4,215.39. The U.S. has the... 
    Via Benzinga
    Topics Stocks
    News headline image
    31 Stocks Moving In Monday's Mid-Day Session ↗
    Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share. Raven Industries, Inc. (NASDAQ: RAVN)... 
    Via Benzinga
    News headline image
    Tarsus Pharmaceuticals' TP-03 Hits Primary, Secondary Endpoints In Demodex Blepharitis Study ↗
    Tarsus Pharmaceuticals Inc (NASDAQ: TARS) has reported topline data from Phase 2b/3 Saturn-1 trial evaluating TP-03 (lotilaner ophthalmic solution, 0.25%) in... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.